WeLeader Biomedical Co., Ltd. (TPEX:7713)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
76.20
+1.90 (2.56%)
Feb 21, 2025, 1:38 PM CST
8.39%
Market Cap 3.17B
Revenue (ttm) 954.87M
Net Income (ttm) 150.66M
Shares Out 41.58M
EPS (ttm) 4.04
PE Ratio 18.85
Forward PE n/a
Dividend 2.30 (3.02%)
Ex-Dividend Date n/a
Volume 26,034
Average Volume 15,937
Open 74.30
Previous Close 74.30
Day's Range 74.30 - 78.20
52-Week Range 66.60 - 86.00
Beta n/a
RSI 45.82
Earnings Date May 13, 2025

About WeLeader Biomedical

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT centr... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies
Founded 1992
Employees 201
Stock Exchange Taipei Exchange
Ticker Symbol 7713
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.